Pacific Biosciences of California, Inc. (FRA:P09)
Germany
· Delayed Price · Currency is EUR 2.046
-0.024 (-1.14%)
At close: Dec 5, 2025
FRA:P09 Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -503.63 | -309.85 | -306.74 | -314.25 | -181.22 | 29.4 | Upgrade
|
| Depreciation & Amortization | 392.71 | 53.35 | 26.53 | 17.32 | 11.59 | 9.3 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | 106.3 | 184.5 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.29 | -13.04 | -12.84 | -0.24 | 4.01 | -0.11 | Upgrade
|
| Stock-Based Compensation | 48.11 | 71.04 | 72.12 | 78.61 | 73.36 | 17.53 | Upgrade
|
| Other Operating Activities | -165.31 | -151.47 | 20.71 | 9.32 | -39.24 | -33.47 | Upgrade
|
| Change in Accounts Receivable | -1.23 | 9.09 | -17.83 | 5.46 | -7.17 | -1.6 | Upgrade
|
| Change in Inventory | 2.15 | -8.32 | -13.84 | -33.91 | -13.11 | -1.62 | Upgrade
|
| Change in Accounts Payable | 4.39 | 1.41 | 0.21 | 1.03 | 6.36 | -5.07 | Upgrade
|
| Change in Unearned Revenue | -2.3 | -2.11 | -10.42 | -3.73 | 25.74 | 0.73 | Upgrade
|
| Change in Other Net Operating Assets | 2.31 | -40.65 | -17.07 | -22.81 | 8.5 | 4.28 | Upgrade
|
| Operating Cash Flow | -122.79 | -206.06 | -259.17 | -263.21 | -111.18 | 19.5 | Upgrade
|
| Capital Expenditures | -3.47 | -6.19 | -8.84 | -16.75 | -5.93 | -1.04 | Upgrade
|
| Cash Acquisitions | - | - | -0.1 | - | -319.79 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -5 | - | - | -0.18 | - | - | Upgrade
|
| Investment in Securities | 156.13 | 130.19 | 13.55 | 133.01 | -352.81 | -218.28 | Upgrade
|
| Investing Cash Flow | 147.66 | 124 | 4.6 | 116.08 | -678.53 | -219.32 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 895.54 | - | Upgrade
|
| Long-Term Debt Repaid | - | -50.69 | -1.84 | -1.61 | -0.36 | -16 | Upgrade
|
| Net Debt Issued (Repaid) | -50.2 | -50.69 | -1.84 | -1.61 | 895.18 | -16 | Upgrade
|
| Issuance of Common Stock | 3.43 | 7.7 | 204.52 | 11.23 | 326.65 | 233.84 | Upgrade
|
| Other Financing Activities | - | - | -93.79 | - | -52.25 | 34 | Upgrade
|
| Financing Cash Flow | -46.77 | -42.99 | 108.89 | 9.62 | 1,170 | 251.84 | Upgrade
|
| Net Cash Flow | -21.91 | -125.04 | -145.68 | -137.51 | 379.87 | 52.02 | Upgrade
|
| Free Cash Flow | -126.26 | -212.25 | -268.02 | -279.96 | -117.11 | 18.46 | Upgrade
|
| Free Cash Flow Margin | -81.68% | -137.81% | -133.66% | -218.20% | -89.73% | 23.40% | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.77 | -1.06 | -1.25 | -0.57 | 0.11 | Upgrade
|
| Cash Interest Paid | 14.81 | 14.81 | 15.69 | 14.05 | 6.93 | 0.49 | Upgrade
|
| Levered Free Cash Flow | 92.04 | -95.64 | -311.67 | 46.5 | -24.54 | -39.58 | Upgrade
|
| Unlevered Free Cash Flow | 97.02 | -87.26 | -302.7 | 55.68 | -16.71 | -39.54 | Upgrade
|
| Change in Working Capital | 5.32 | -40.58 | -58.96 | -53.97 | 20.33 | -3.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.